Bimekizumab

Drug Name
Bimekizumab

Brand Name(s)
Bimzelx®

Drug Class
Biologic

Bimekizumab is used to treat inflammatory conditions such as ankylosing spondylitis (AS), non-radiographic axial spondyloarthritis, psoriatic arthritis (PsA), and psoriasis. It works by binding to an inflammatory cytokine called IL-17A and IL-17F to reduce inflammation. Since it affects the immune system, it can also increase the risk of infections.

This information was last updated in June 2024 with expert review and advice by:

Alan Low, BSc(Pharm), PharmD, ACPR, FCSHP, CCD, RPh
Clinical Professor, Faculty of Pharmaceutical Sciences, University of British Columbia
Pharmacy Lead and Primary Care Pharmacist, BioPro Biologics Pharmacy 
Care Director, MedInfuse Health

Garrett Tang, PharmD, RPh
Pharmacist Services Coordinator, MedInfuse Health

We also thank previous expert contributor:

Jason Kielly, BSc(Pharm), PharmD
Assistant Professor, School of Pharmacy, Memorial University of Newfoundland
Clinical Pharmacist, Rheumatic Health Program, Eastern Health

Go Back to Drug Index